• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Dyax Corporation Product Image

Dyax Corporation

  • Published: September 2008
  • 27 pages
  • Datamonitor

The Dyax Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Dyax discovers, develops and commercializes biopharmaceuticals primarily in the areas of inflammation and oncology. The company, through its proprietary drug discovery technology, known as phage display, identifies antibody, small protein and peptide compounds for clinical development. The company is headquartered in Cambridge, Massachusetts and employed 177 people as of December 2007. The company recorded revenues of $26.1 million during the financial year (FY) ended December 2007, as compared to total revenues of $12.8 million in 2006. The increase of $13.3 million in revenue from 2006 to 2007 was primarily due to the recognition of $15 million in revenue from the company’s license agreement signed with MorphoSys in November 2007. The operating loss of the company was $50.5 million during FY2007, as against an operating loss of $49.8 million in 2006. The net loss was $11.9 million READ MORE >



This product typically includes the following sections:

Key Facts
Company Overview
Business Description
Company History
Key Employees
Key Employee Biographies
Company View
SWOT analysis
Products & Services Listing
Products & Services Analysis

Format Properties
Electronic (PDF) This company profile will be emailed to you. The company profile is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS